Africa HIV Therapeutics Market Analysis

Africa HIV Therapeutics Market Analysis


$ 3999

The Africa HIV therapeutics market is expected to reach $282.62 Mn by 2030, up from $150.45 Mn in 2022, with a CAGR of 8.2% from 2022 to 2030. African players such as Fidson Healthcare Plc, Saidal Group, Biopharm, and EVA Pharma dominate the Africa HIV therapeutics market. The African government policies, funding, poverty, and initiatives by international organizations to manage HIV infections propel the market. The Africa HIV therapeutics market is divided into five segments type, product, geography, end user, and distribution channel.

ID: IN10AFPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Africa AUTHOR: Vishwa Modhia

Buy Now

Africa HIV Therapeutics Market Analysis Summary

The Africa HIV therapeutics market is expected to reach $282.62 Mn by 2030, up from $150.45 Mn in 2022, with a CAGR of 8.2% from 2022 to 2030.

Eastern and southern Africa continue to be the most severely affected by HIV, with 20.6 Mn [18.9 Mn-23.0 Mn] people—54% of all HIV patients worldwide. In Western and Central Africa, there will be 5 Mn [4.5 Mn-5.6 Mn] HIV-positive people by the end of 2021. The region has the world's third-highest HIV burden, with five countries accounting for roughly two-thirds of all people living with HIV in the region. Women and girls continue to be disproportionately affected by HIV, accounting for 63% of new HIV infections in the region in 2021. Adolescent girls and young women (aged 15 to 24 years) have three times the number of new HIV infections as males of the same age.

The region is making progress toward the 95-95-95 targets. By 2021, 80 % of people living with HIV were aware of their HIV status, 98 % of those who were aware of their HIV-positive status were receiving treatment (78 % of all people living with HIV), and 88 % of those on treatment had suppressed viral loads (69 % of all people living with HIV).

Africa HIV Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Several initiatives and organisations have been formed to support HIV treatment and care in Africa. The African Society for Laboratory Medicine (ASLM), for example, works to improve laboratory services across the continent in order to aid in the diagnosis and treatment of HIV and other infectious diseases. The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set the goal of ending the African AIDS epidemic by 2030 through a combination of prevention, treatment, and care efforts. This includes expanding HIV testing and counselling services, addressing stigma and discrimination, and strengthening health systems to support HIV treatment and care.

Recent progress is reflected in the expansion of differentiated service delivery models, which have assisted in mitigating the impact of the COVID-19 pandemic on access to services, but children living with HIV are falling behind: only 35% had access to antiretroviral therapy in 2021. These elements may entice new entrants into the African HIV therapeutics market.

Market Restraints

Despite this progress, new HIV infections must be reduced faster if the region is to eliminate AIDS as a public health threat by 2030. Regional gains also obscure slower progress in places like Madagascar and South Sudan, where new HIV infections have increased since 2010. The regional HIV response faces significant challenges, including the lingering effects of the COVID-19 pandemic, which disrupted services and caused some countries to reallocate scarce health resources away from the HIV response. Civil unrest, drought, and flooding also impede HIV service provision and undermine countries' commitment to continue prioritising HIV response. These factors may discourage new entrants to enter Africa's HIV therapeutics market.

Competitive Landscape

Key Players

  • FHI 360 (EGY)
  • EVA Pharma (EGY)
  • Aspen Pharmacare (ZAF)
  • Adcock Ingram (ZAF)
  • Cipla Medpro (ZAF)
  • Saidal Group (DZA)
  • Biopharm (DZA)
  • Fidson Healthcare Plc (NGA)
  • Merck & Co.
  • AbbVie
  • Bristol Myers Squibb

Recent Notable Updates

January 2023: The US government spent over $7.8 Bn on the President's Emergency Plan for AIDS Relief (PEPFAR) to help Nigeria fight HIV/AIDS. The investment provided antiretroviral treatment to over 1.9 Mn Nigerians (ART).

December 2022: EVA Pharma is launching an HIV awareness campaign in collaboration with Egypt's Ministry of Health and UNAIDS. The Egyptian Ministry of Health and Population's National AIDS Control Program has launched a new campaign to combat HIV discrimination and address societal fears about the disease in collaboration with the Joint United Nations Programme on HIV/AIDS (UNAIDS) and leading pharmaceutical company EVA Pharma. The "Zay Ay Marad" ("Like Any Disease") campaign was launched in conjunction with World AIDS Day. The programme aims to coordinate efforts with all parties to combat the disease, reduce infections, and keep Egypt's low-infection rate, all while working to eradicate AIDS in Egypt and meet the 2030 Sustainable Development Goals.

March 2022: ViiV Healthcare's injection, which was approved by the US Food and Drug Administration, provides two months of HIV protection and contains the active ingredient cabotegravir. The ground-breaking announcement was made at the World Health Organization (WHO), and it is hoped that it will increase HIV prevention globally. The first injection to provide long-term HIV protection is being rolled out in South Africa and Brazil as an alternative to daily medication.

Healthcare Regulations

Regulation of HIV therapeutics in Africa varies widely depending on the country and the specific region. The Egyptian Drug Authority (EDA) is the regulatory body in charge of the approval and oversight of medicines, including HIV therapeutics, in Egypt. The South African government has established the South African Health Products Regulatory Authority (SAHPRA) to oversee the registration, licencing, and regulation of all health products in the country, including HIV therapeutics. In Algeria, the National Agency for Food and Drug Administration and Control (NAFDAC) is in charge of registering, licencing, and regulating all medicines and health products. The Pharmacy and Poisons Board (PPB) in Kenya is the regulatory body in charge of the registration and oversight of pharmaceutical products, including HIV therapeutics.

Reimbursement Policies

Access to HIV treatment and care in Africa has improved significantly in recent years, but challenges remain, and the reimbursement of HIV therapeutics varies across different countries and regions on the continent. Many countries, including those with the highest HIV burdens, such as South Africa, Nigeria, and Uganda, have national health insurance schemes or other programmes that cover HIV treatment, such as antiretroviral therapy (ART) and other medications used to treat HIV-related conditions. These programmes are frequently supported by a mix of government, international aid, and private insurance funds. However, access to HIV treatment and care remains limited in many parts of Africa, particularly in rural areas where health infrastructure is often inadequate, and treatment costs can be prohibitive for many people. In some cases, patients may be required to pay for HIV therapeutics out of pocket, or they may not have access to the most recent medications or treatments.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 February 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up